Summary
41 / 100 · Bulios Score
What speaks for it
- It has no debt and holds $111.2M in cash.
- The share price is below the Bulios Fair Price.
- It bought back its own shares for $56.2M in the last fiscal year, 8.1% of its market value.
What to watch
- The company made a loss over the last 12 months.
- Revenue growth is slowing: 1.3% a year over the last 3 years against 22% over 5 years.
- It passes only 3 of the 9 points of the Piotroski financial health test.
- It missed profit estimates 4 times in the last 8 quarters.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
The company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 22% a year over 5 years. Over the last 3 years it grew by 1.3% a year.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $17.2M.
Profitability in detailIs it financially healthy?
YesIt has no debt.
Financial health in detailDoes it pay a dividend?
Moderate, at risk- Yield
- 4.80%
You receive $0.20 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 1
- Hold 1
- Sell 0
Today's price within the analysts' price targets
The average target of $6.5 is 56% above today's price. 50% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.